Gracell Biotechnologies Company
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Technology:
CAR-T
Industry:
CAR-T
Headquarters:
Suzhou, Jiangsu, China
Founded Date:
2017-01-01
Funding Status:
Late Stage Venture
Investors Number:
13
Total Funding:
185000000
Estimated Revenue:
$1M to $10M
Register and Claim Ownership